DCP, a protein induced by vitamin K absence or antagonist-II (PIVKA-II), is major serum biomarkers for the detection of HCC, increasing in 95% aHCC patients with a diameter greater than 5 cm [15]. This evidence concerns the gene ACE and hepatocellular carcinoma.